LabGenomics Co. Ltd (084650) — Financial Flexibility Index
LabGenomics Co. Ltd (084650) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of ₩-5.93 Billion (operating CF ₩-6.41 Billion minus capex ₩480.02 Million) represents 0% of total liabilities (₩76.00 Billion). Check 084650 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LabGenomics Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for LabGenomics Co. Ltd across 11 annual periods. See LabGenomics Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for LabGenomics Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for LabGenomics Co. Ltd. For the full company profile including market capitalisation, see market value of LabGenomics Co. Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.11x | ₩-8.45 Billion | ₩-12.99 Billion | ₩79.35 Billion | ▼ -219.2% |
| 2023 | 0.09x | ₩7.62 Billion | ₩2.42 Billion | ₩85.31 Billion | ▼ -96.6% |
| 2022 | 2.62x | ₩108.20 Billion | ₩69.87 Billion | ₩41.32 Billion | ▲ +54.2% |
| 2021 | 1.70x | ₩79.08 Billion | ₩65.36 Billion | ₩46.57 Billion | ▲ +0.4% |
| 2020 | 1.69x | ₩47.07 Billion | ₩46.37 Billion | ₩27.82 Billion | ▲ +760.2% |
| 2019 | 0.20x | ₩3.75 Billion | ₩3.19 Billion | ₩19.06 Billion | ▲ +26.8% |
| 2018 | 0.16x | ₩2.64 Billion | ₩608.03 Million | ₩16.99 Billion | ▼ -16.3% |
| 2017 | 0.19x | ₩3.25 Billion | ₩-1.06 Billion | ₩17.52 Billion | ▼ -49.1% |
| 2016 | 0.36x | ₩6.62 Billion | ₩2.54 Billion | ₩18.17 Billion | ▼ -50.4% |
| 2015 | 0.73x | ₩7.00 Billion | ₩2.38 Billion | ₩9.54 Billion | ▲ +66.4% |
| 2014 | 0.44x | ₩4.35 Billion | ₩3.15 Billion | ₩9.86 Billion | — |